Home > Haematology > Limited evidence supports many hematopoietic stem cell transplant guidelines

Limited evidence supports many hematopoietic stem cell transplant guidelines


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
JAMA Network Open
Reuters Health - 19/10/2021 - Guidelines for hematopoietic stem cell transplants often are not supported by randomized clinical trials published in peer-reviewed journals, a new study finds. Researchers examined how often there was evidence from randomized trials published in peer-reviewed journals to support recommendations laid out by the American Society for Transplantation and Cellular Therapy (ASTCT) 2020 guidelines for indications with standard of care alone or combined with clinical evidence. They focused on research published for both allogenic and autologous transplant. In total, the study examined 103 ASTCT recommendations for allogenic and autologous transplant. For allogenic transplant, the researchers identified 43 recommendations with indications for standard of care alone and 27 recommendations that also included clinical evidence. For autologous transplant, they found 23 indications based on standard of care alone and 18 combined with clinical eviden...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on